TrialThe oncologist2011

Report of a phase II study of clofarabine and cytarabine in de novo and relapsed and refractory AML patients and in selected elderly patients at high risk for anthracycline toxicity.

Edward Agura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.